INS and type 2 diabetes mellitus: Conversely, there is limited evidence that MFGM and the associated PL components of dairy may improve CV and T2D intermediary endpoints, in RCTs of 1 day to 12 weeks duration reporting outcomes including lipid metabolism, inflammatory response and insulin resistance.